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Anti-idiotype RNAs that mimic the leucine-rich nuclear export
signal and specifically bind to CRM1/exportin 1
Jörg Hamm1 and Maarten Fornerod2
Background: Anti-idiotype approaches are based on the assumption that an
antibody recognising a ligand can be structurally related to the receptor.
Recently we have generated anti-idiotype RNA aptamers designed to mimic the
human immunodeficiency virus-1 (HIV-1) Rev nuclear export signal (NES).
Nuclear injection of either NES–peptide conjugates or aptamer causes the
inhibition of Rev-mediated export. This implied that NES mimics and export
substrate might compete for binding to the NES receptor. The mechanism of
inhibition, however, is unknown.
Results: The interaction between the export aptamer and CRM1 was
characterised in vitro. The aptamer binds specifically to CRM1 and this
interaction is sensitive to competition by Rev NES–peptide conjugates. The
recognition domain of CRM1 has been mapped and includes residues found
previously to affect binding of leptomycin B, a fungicide interfering with 
nuclear export.
Conclusions: Inhibition of Rev-mediated export in vivo by export aptamers
appears to result from the binding of the aptamers to the NES-recognition
domain of CRM1. This observation demonstrates that anti-idiotype RNA can
mimic faithfully structural and functional properties of a protein and can be used
to map ligand-binding domains of receptors.
Background
The transport of macromolecules across the nuclear enve-
lope is a saturable temperature- and energy-dependent
process. Cargo molecules contain targeting sequences,
which are recognised by soluble receptors either directly
or via adaptors. The receptors interact with nucleoporins,
which are part of nuclear pore complexes (NPCs), large
proteinaceous regulated channels that span the nuclear
membrane [1–3].
The majority of nuclear transport receptors belong to a
protein super family that is prototyped by importin β, the
nuclear import receptor of basic nuclear localisation signal
(NLS) proteins [4,5]. Importin-β-like transport receptors
have binding sites for their different cargoes, nucleoporins
and RanGTP (the nuclear form of the small GTPase Ran).
RanGTP dissociates importin–cargo complexes and sta-
bilises exportin–cargo complexes, thus imposing direction-
ality on this type of receptor-mediated nucleocytoplasmic
transport [3,6]. Among the first exportins described was
CRM1 (also known as exportin 1 [7–10]) the export recep-
tor for leucine-rich nuclear export signals (NESs).
Most of what is known about nuclear export is the result of
studies of the human immunodeficiency virus-1 (HIV-1)
Rev protein. Rev is required for the export of unspliced
HIV-1 mRNA from the nucleus to the cytoplasm [11]. The
transport pathway used by Rev appears to be conserved
across species, as Rev-mediated export has been observed
in yeast, Xenopus oocytes and mammalian cells [7–10]. Fur-
thermore, all of the species examined contain highly related
CRM1 proteins, which include a central portion of roughly
200 amino acids that is almost identical in all proteins.
Rev contains a leucine-rich NES and mutation of the NES
interferes with Rev-mediated export [12–14]. It was,
therefore, proposed that the inability of NES mutants of
Rev to facilitate export could be due to their lack of
binding to essential transport factors, such as CRM1. This
model is in agreement with data showing that the forma-
tion of a stable trimeric complex comprising Rev, CRM1
and RanGTP requires an intact NES [7]. Furthermore,
the fungicide leptomycin B (LMB), which inhibits Rev-
mediated export, can bind directly to CRM1 and inter-
feres with the formation of a stable trimeric export
complex [7,15]. These observations, however, do not
exclude the existence of intermediate dimeric complexes.
Although no stable CRM1–Ran dimer could be detected
[7], a stable CRM1–Rev complex has been characterised
recently [16], but the observed dimeric complexes are
unlikely to be productive export complexes.
Anti-idiotype RNA aptamers were previously isolated
from combinatorial RNA libraries [17–22] with an antibody
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that recognised the Rev NES–peptide [23]. These
aptamers specifically inhibited CRM1-mediated nuclear
export when co-injected with export substrates into the
nucleus of Xenopus oocytes, exactly as observed with
NES–peptide conjugates [24], and were therefore named
export aptamers (XAPs). It appeared likely that the
inhibitory effect of the XAPs was due to competition with
Rev for binding to the NES receptor. At that time,
however, this model could not be tested directly because
CRM1 had not been identified as the NES receptor. In
this work, we describe the characterisation of the inter-
action between the RNA aptamers and purified, recombi-
nant transport factors in vitro. The export aptamers bind
specifically to CRM1 and the strength of this interaction
facilitated the mapping of a putative NES-recognition
domain of CRM1, which appears to co-localise with the
LMB binding site. These results provide strong evidence
that the anti-idiotype RNA method functions as predicted
and suggest that it might be generally useful both in the
analysis of protein–protein interactions and in generating
inhibitors that target these interactions.
Results
Export aptamers bind specifically to CRM1
To investigate whether the putative RNA mimics of Rev
NES were able to interact with the NES-receptor CRM1
in vitro, we performed binding studies with purified,
recombinant transport factors produced in bacteria. We
used one of the previously described export aptamers,
XAP1 [23], for the experiments reported here. This RNA
is predicted to form a perfect 18 basepair (bp) stem closed
by a three-layer G-quartet structure and is representative
of the family of sequences isolated with an anti-
NES–peptide antibody. Other export aptamers behaved
identically to XAP1, both in the export competition
studies performed previously and in the binding studies
with purified transport factors [23] (and data not shown).
Two mutant RNAs derived from XAP1 served as highly
specific control RNAs for the experiments. These RNAs,
VGG and VTL, share some structural similarities with
XAP1 but failed to interact with the anti-NES antibody
and did not inhibit Rev-dependent export when injected
into the nucleus of Xenopus oocytes [23]. Both of these
variant RNAs have the 18 bp stem element that is
present in XAP1, but differ in the sequences closing the
stem. VTL carries a stable tetraloop sequence (UUCG),
whereas in VGG only two of the three G residues are
present in each of the four groups of G residues found in
XAP1. Furthermore, tRNA and 5S RNA were included
as additional controls.
The interaction between radioactively labelled XAP1 and
transport factors was studied by native gel analysis of
RNA–protein complexes. A stable complex was easily
detectable after a short incubation of CRM1 with XAP1
(Figure 1a). Quantification of this CRM1 titration experi-
ment indicates that the apparent Kd value of the
XAP1–CRM1 interaction is about 100 nM (Figure 1b). No
complexes were observed when the specific control RNAs
VGG and VTL (Figure 1c, lanes 5 and 7) or unrelated RNAs
(Figure 1c, lanes 9 and 11) were analysed under identical
conditions. Furthermore, no interaction between export
aptamers and the transport receptors importin β
(Figure 1c, lane 1) or exportin (tRNA) (Figure 1c, lane 13)
were observed. We therefore conclude that export
aptamers bind specifically to the NES receptor CRM1
in vitro. In addition, there is a perfect correlation between
the ability of RNAs to bind to CRM1 in vitro and the
ability to inhibit CRM1-dependent transport in vivo.
The interaction of export aptamers and CRM1 was not
sensitive to the presence or absence of RanGTP or
RanGDP in our experiments. RanGTP did not stimulate
complex formation and we did not detect a complex con-
taining CRM1, Ran and XAP1. This is in contrast to what
is observed with Rev–CRM1 complexes. Although Rev
can bind to CRM1 in the absence of RanGTP, binding is
stimulated greatly by the presence of RanGTP [7,14,16].
The lack of stimulation of XAP1 binding by RanGTP
might be due to a number of factors: steric hindrance
when XAP1 and RanGTP are both in complex with
CRM1, differences in the conformation of CRM1 induced
upon binding, or RanGTP–NES interactions that are not
mimicked by XAP1.
Structural requirements of the export aptamers
Based on the sequence of the selected export aptamers,
we had suggested that the RNA would form an 18 bp stem
closed by a three-layered G-quartet structure. The
binding assay with recombinant CRM1 allowed us to test
this prediction experimentally.
Folding of G-quartet structures is known to require potas-
sium ions which intercalate between individual quartet
layers [25]. We therefore anticipated that XAP1 would not
fold properly in the absence of potassium ions and conse-
quently would fail to bind to CRM1 if a G-quartet struc-
ture was part of the binding site. XAP1 was renatured in
the presence of either sodium or potassium ions and incu-
bated with recombinant CRM1 in a potassium-free buffer,
prior to native gel analysis. Complexes were observed
when XAP1 had been renatured in the presence of potas-
sium ions (Figure 2a, lane 4) but not in the presence of
sodium ions (Figure 2a, lane 2). Furthermore, we had
noted previously that XAP1 that is not bound to CRM1
migrates at two distinct positions in the native gel system
(Figure 2a, lane 3). Based on the results of the renatura-
tion test it appears that only the slower migrating band
corresponds to correctly folded XAP1, because this band
was not detected when RNA was renatured in the absence
of sodium ions (Figure 2a, compare lanes 1 and 3). This
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interpretation would be in agreement with the observation
that only the upper band of the XAP1 doublet disappears
upon addition of CRM1 (Figure 1a, compare lanes 2 and
11; Figure 2a, compare lanes 3 and 4). In addition, the pro-
portion of the RNA migrating at the upper position was
much lower for the variant VGG (Figure 1c, compare lanes
2 and 4). This variant could, at best, form only a two-
layered quartet structure, which would have reduced sta-
bility compared to a three-layered structure. The
observation that VGG shows only weak binding to CRM1
could, therefore, be due to the inefficient formation of the
G-quartet structure.
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Figure 1
XAP1 binds to CRM1. (a) Titration of CRM1.
Radioactively labelled export aptamer XAP1
(1 nM) was incubated with increasing
amounts of purified, recombinant CRM1
(0–1800 nM) and CRM1–XAP1 complexes
were analysed on native acrylamide gels.
(b) Quantification of XAP1–CRM1 interaction.
The relative amount of RNA (%) present in
CRM1–XAP1 complexes from the titration
shown in (a) was quantified and plotted
against the CRM1 concentration.
(c) Specificity of XAP1 binding to CRM1.
Radioactively labelled (XAP1), mutant RNAs
(VTL and VGG) unable to bind an anti-NES
antibody in vitro or to inhibit export in vivo,
and unrelated RNAs (tRNA and 5S RNA)
were incubated (all RNAs 1 nM) with purified,
recombinant proteins (CRM1, importin β [imp-
β], exportin (tRNA) [xpo1t]; 200 nM) and
complexes analysed on native gels. The
positions of free RNA and of RNA–protein
complexes are indicated on the left-hand side
of the figure.
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The 18 bp stem present in XAP1 was part of the structural
constraint incorporated into the RNA library, and was not
due to a selective pressure applied during the selection
process. We therefore wanted to establish whether a stem
was necessary for formation of the active XAP1 structure.
The stem was reduced in steps of two basepairs from
18 bp to 6 bp and the stem variants of XAP1 were then
tested for their ability to bind CRM1 (Figure 2b). XAP1
with a 8 bp stem was still able to bind to CRM1
(Figure 2b, lane 6), whereas a further reduction of the
stem length resulted in loss of a detectable interaction.
We conclude that functional XAP1 appears to form a
three-layered G-quartet structure that requires a stem of
at least 8 bp, possibly for coaxial stacking of the G-quartet
and the stem structure.
NES–peptide conjugates and leptomycin B block binding
of the export aptamers to CRM1
CRM1-dependent transport in vivo is blocked by
NES–peptide conjugates and RNA mimics of NES. Fur-
thermore, it has been shown that Rev can interact specifi-
cally with CRM1 in the absence of RanGTP [16].
Competition experiments were therefore performed to
investigate whether peptides and RNA would target the
same CRM1 domain in vitro. As anticipated, pre-incuba-
tion of CRM1 with bovine serum albumin (BSA)–Rev
NES–peptides conjugates interfered with the formation of
XAP1–CRM1 complexes (Figure 3, lane 3), whereas BSA
alone had no effect (Figure 3, lane 2). The results of this
competition experiment indicate that the NES peptide
and XAP1 compete for the same CRM1 domain. A quan-
tification of the NES-competition experiment is not possi-
ble due to the low affinity of NES peptides or Rev protein
348 Chemistry & Biology  2000, Vol 7 No 5
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(a) (b)
Structural requirements for the binding of XAP1 to CRM1. (a) CRM1
binding of the RNA mimics requires potassium ions. RNA (XAP1) was
renatured in the presence of either potassium or sodium ions (100 mM
each, +1 mM MgCl2, 10 mM Tris pH 7.5) prior to incubation with
recombinant CRM1 in potassium-free buffer (50 mM Tris-HCl pH 7.5,
150 mM NaCl, 5 mM MgCl2). Complexes formed were analysed on
native acrylamide gels. The active conformation of the free RNA is
indicated by an asterisk (*) on the right-hand side of the
figure. (b) A minimum stem of 8 bp is required to form the functional
RNA. The length of the predicted stem of XAP1 (18 bp) was reduced
gradually from 12 bp to 6 bp and the stem variants were analysed for
their ability to bind recombinant CRM1 as in (a).
Figure 3
NES–peptide conjugates compete with XAP1 for binding to recombinant
CRM1. Radioactively labelled export aptamer (XAP1, 0.2 nM) was
incubated with recombinant CRM1 (200 nM) in the presence of 10 µg
BSA or BSA–peptide conjugate (BSA–Rev NES; 10 µg = 1.8–2.3 nmol
NES, NES concentration = 90–110 µM) and analysed on native gels.
B
S
A
B
S
A
–R
ev
 N
E
S
1 2 3
Free RNA
Competitor
CRM1 complex
Chemistry & Biology
cm7502.qxd  05/03/2000  09:07  Page 348
for CRM1 in the absence of RanGTP [16]. Furthermore,
as is generally true for unconstrained peptides, only a sub-
fraction of the NES peptides will be in the proper confor-
mation compatible with binding to CRM1. A detailed
numerical quantification would, therefore, be likely to
claim a precision that is impossible to achieve and has con-
sequently not been attempted.
LMB is an inhibitor of CRM1-dependent export in vivo
and it has been shown that LMB interferes with the for-
mation of NES–RanGTP–CRM1 complexes in vitro
[7,26]. Although it has been demonstrated that LMB can
bind directly to CRM1 in vitro, it is not known whether
LMB competes with the NES or with RanGTP for
binding to CRM1. To address this issue we pre-incubated
CRM1 in the presence or absence of LMB and analysed
binding of XAP1. Complex formation was severely
reduced in the presence of 10 µM LMB (Figure 4, lane 8),
whereas lower LMB concentrations had little effect
(Figure 4, lanes 3–6 and data not shown). These experi-
ments suggest that the export aptamers are capable of
binding to CRM1 in a NES-like fashion.
Mapping of recognition domains of CRM1
As with other transport receptors of the importin-β super-
family, CRM1 contains a putative Ran-binding domain,
which is located at the amino terminus of the protein. In
addition, the comparison of human, Saccharomyces cerevisiae
and Schizosaccharomyces pombe CRM1 sequences revealed a
stretch of ~200 amino acids located in the centre of the
protein that is absolutely conserved between species.
Point mutations that were found to affect the sensitivity of
CRM1 to LMB in S. pombe are also located in this central
area of CRM1 [27].
It was therefore anticipated that CRM1 might contain a
Ran-binding domain located at the amino terminus, an
LMB-binding domain in the central region and a sub-
strate-binding domain at the carboxyl terminus. Initial
attempts to separate functional domains using binding
studies with NES peptides and CRM1 deletion mutants
with some of these domains missing were unsuccessful
due to the cooperativity of the binding of RanGTP and
substrate to CRM1 (M.F., unpublished observations). The
ability of XAP1 to bind strongly and specifically to CRM1
in the absence of Ran, however, led us to test the deletion
mutants for their ability to bind to the export aptamer.
Truncated CRM1 proteins were translated in vitro in the
presence of radioactively labelled amino acids and precipi-
tated with biotinylated RNAs coupled to streptavidin
beads. XAP1 was the experimental RNA used and mutant
RNA variants were used as negative controls. The putative
Ran-binding domain was deleted either alone or in combi-
nation with a carboxy-terminal domain to evaluate the fea-
sibility of this approach for mapping the NES-recognition
domain of CRM1. Both of the deletion mutants lacking the
amino terminus of CRM1 (CRM1[276–705] and
CRM1[261–1071]) can be precipitated specifically by
XAP1, indicating that the putative Ran-binding domain is
not required for interaction with the NES mimic
(Figure 5a, lanes 5 and 8). In addition, the deletion of
carboxy-terminal amino acids between positions 706 and
1071 did not affect binding to XAP1 (Figure 5a, lanes 2 and
5). We therefore reasoned that the putative NES-recogni-
tion domain of CRM1 might be located in the central part
of the protein and a second set of deletion mutants was
tested to map this domain more precisely.
We focused our attention on the most highly conserved
central portion of CRM1, residues 416–600 (the number-
ing corresponds to the human CRM1 sequence), for the
second part of the analysis. An even smaller fragment was
constructed that comprises only amino acids 493–600 but
still contains the amino acids known to affect LMB sensi-
tivity of CRM1 in S. pombe when CRM1 is mutated (corre-
sponding to Gly502 and Met545 in human CRM1
[27–29]). As an additional control for specific precipitation
of labelled proteins, we generated a fragment from the
Ran-binding region (CRM1[1–278]) alone. The Ran-
binding domain fragment was not precipitated by any of
the biotinylated RNAs (Figure 5b, lanes 1–6), as would
have been expected from the results of the experiment
shown in Figure 5a. In contrast, both CRM1[416–600] and
CRM1[493–600] bound specifically to export aptamers
(Figure 5c,d, lane 2) but not to any of the control RNAs
(Figure 5c,d, lanes 3–6). The results of the binding studies
with partial CRM1 proteins suggest that the XAP1-
binding region, and therefore the likely NES-recognition
domain of CRM1, is part of the highly conserved, central
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Figure 4
Binding of XAP1 is leptomycin B (LMB) sensitive. Radioactively
labelled export aptamer (XAP1, 1 nM) was incubated with recombinant
CRM1 (200 nM) in the presence of LMB (0–10 µM) and analysed on
native gels.
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part of the protein. Furthermore, the NES- and LMB-
recognition domains of CRM1 appear to colocalise [28,29].
Export aptamers bind CRM1 present in nuclear extracts
The experiments described above demonstrate that RNA
mimics of the Rev NES–peptide interact specifically with
the NES receptor CRM1. Furthermore, the export inhibi-
tion studies performed in oocytes suggest that RNA mimics
could interact with CRM1 in vivo. It would therefore
appear possible to isolate an unidentified receptor for a
known ligand using an anti-idiotype approach similar to the
one which resulted in the isolation of the export aptamers
[23]. It might be sufficient to use the RNA mimics of a
ligand domain to generate an affinity purification column to
enrich the receptor for identification from nuclear extracts.
We performed a simple test experiment to verify this
hypothesis by incubating immobilised RNA mimics or
350 Chemistry & Biology  2000, Vol 7 No 5
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The NES-recognition domain of CRM1 is located in the evolutionarily
highly conserved central part of the protein. CRM1 deletion mutants
(the amino acids of CRM1 present in the partial CRM1 proteins are
indicated) were translated in vitro in the presence of [35S]-methionine
and incubated together with competitor RNA (tRNA) and biotinylated
RNA bound to streptavidin beads (no RNA: –, RNA mimic: XAP1,
control RNA: VGG, VTL, tRNA or 5S RNA). Beads were washed
extensively with buffer (50 mM Tris-HCl pH 7.5,100 mM KCl, 50 mM
NaCl, 5 mM MgCl2, 0.1% NP-40), proteins were eluted with sodium
dodecyl sulphate (SDS)gel sample buffer and analysed on SDS gels.
An aliquot of the untreated translation reaction was loaded in (b–d) for
comparison (input). (a) Mapping of the XAP1-binding domain of
CRM1. Large deletions were introduced either separately or in
combination at the amino terminus (CRM1[261–1071] and
CRM1[276–705], to remove the putative Ran-binding domain) and at
the carboxyl terminus of CRM1 (CRM1[1–705], CRM1[276–705]).
(b) The amino-terminal, putative Ran-binding domain (CRM1[1–278])
is not recognised by RNA mimics of NES. (c) The XAP1-binding
domain is localised in the evolutionarily highly conserved central 200
amino acids (CRM1[416–600]). The faster migrating protein, which is
still precipitated specifically by XAP1, is likely to be due to initiation of
translation at a site downstream of position 416. We did not attempt to
localise the precise position of this aberrant initiation site (located only
slightly downstream of position 416, but far upstream of position 493)
further due to the results shown in (d). (d) A fragment of 108 amino
acids (CRM1[493–600]) comprising amino acids known to affect LMB
sensitivity in S. pombe binds specifically to XAP1.
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control RNAs with HeLa cell nuclear extracts. The affin-
ity beads were washed several times with buffer, bound
proteins were eluted with denaturing buffer, separated on
SDS-acrylamide gels and analysed by silver staining.
Despite the simple experimental design, most of the pro-
teins present in HeLa nuclear extract were not precipi-
tated by the beads (Figure 6a, compare lane 1 with lanes
2–4). Furthermore, beads coated with XAP1 precipitated
specifically a limited number of proteins, one of them
migrating at the position corresponding to that expected
for CRM1 (Figure 6a, lane 3, labelled ‘X’).
Proteins precipitated by the RNA-coated beads were
analysed by probing western blots with various antibodies.
CRM1 was precipitated from nuclear extracts only by the
mimic XAP1 (Figure 6b, lane 2; Figure 6c, lane 2
[CRM1]) and not by the control RNAs (Figure 6b, lanes 3
and 4; Figure 6c, lanes 3–6 [CRM1]). Furthermore,
neither importin-β (Figure 6c [imp-β]) nor exportin
(tRNA) (data not shown) were precipitated by XAP1.
Although the enrichment for CRM1 was only moderate in
our one-step pull-down experiments, it does appear possi-
ble to use an affinity enrichment with ligand-mimics sub-
sequent to using conventional chromatographic
purification steps to identify unknown receptors.
Discussion
The anti-idiotype approach
RNA aptamers that might resemble the HIV-1 Rev NES
peptide were produced by an anti-idiotype approach [23].
Transport inhibition studies performed in Xenopus oocytes
had shown that the so-called ‘export aptamers’ were
capable of specifically blocking nuclear-export pathways
[23]. This led to the prediction that the export aptamers
were binding to the NES receptor CRM1 in vivo and
interfering with export by competing with genuine export
substrates for the NES-recognition domain. This model
was based on a number of indirect experimental observa-
tions. Export aptamers and NES peptides competed for
binding to the anti-NES antibody that had been used to
generate the anti-idiotype RNAs, thus indicating that the
export aptamers and NES peptides might share some
structural similarity. Furthermore, co-injection of export
substrates and export aptamers showed that only Rev- and
cap-dependent export were inhibited, whereas tRNA
export, which is known to use a different export pathway
[3], was unaffected. In addition, the export aptamers were
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Figure 6
XAP1 precipitates CRM1 from HeLa cell nuclear extracts.
(a) Biotinylated XAP1 and a mutant form of XAP1 (VTL) or streptavidin
magnetic beads alone (no RNA) were incubated in HeLa nuclear
extract and RNA–protein complexes were precipitated and washed
with buffer (50 mM Tris-HCl (pH 7.5), 100 mM KCl, 50 mM NaCl,
5 mM MgCl2, 0.1% NP-40). Proteins were eluted from the beads,
separated on SDS gels and analysed by silver staining. HeLa nuclear
extract (NXT, 1 µg) was loaded on the same gel for comparison. A
protein migrating at the position expected for CRM1 is indicated on
the right (labelled X). (b) Biotinylated XAP1 and mutant forms of XAP1
(VGG and VTL) or unrelated RNAs (tRNA or 5S RNA) bound to
streptavidin magnetic beads, or streptavidin magnetic beads alone (no
RNA), were incubated in HeLa nuclear extract and RNA–protein
complexes were precipitated and washed as described in (a). Proteins
were eluted from the beads, separated on SDS gels and analysed by
western blotting with anti-CRM1 antibodies. The position of intact
CRM1 is indicated by the arrow, the weaker signal around 80 kDa
corresponds to a degradation product of CRM1. (c) Western blot of
precipitated proteins probed with anti-CRM1 antibodies (CRM1) or
with anti-importin-β antibodies (imp-β). For comparison, 5 µg HeLa
nuclear extract was loaded on the same gel (NXT).
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actively transported into the cytoplasm after nuclear injec-
tion. Finally, RNA mutants unable to bind to the anti-
NES antibody did not inhibit nuclear export nor were
they transported actively after nuclear injection. Before
we can conclude confidently that an anti-idiotype
approach could be useful to study receptor–ligand interac-
tions it was essential, however, to demonstrate directly
that the export aptamers did recognise CRM1 specifically.
The results of our present study show that the export
aptamers interact specifically with CRM1 but not with
the related transport receptors importin-β or exportin
(tRNA). Furthermore, only functional export aptamers
that were both actively transported in oocytes and
capable of inhibiting CRM1-dependent export bind to
purified CRM1 in vitro. The lack of detection of
CRM1–Ran–export aptamer complexes in vitro demon-
strates that there are differences in export aptamer and
NES peptide binding to CRM1. These differences could
be due to the incompatibility of the presence of both Ran
and an export aptamer in a single complex. Incompatibil-
ity could be caused by steric hindrance, or by electrostatic
charges present in the RNA mimic, or its inability to
make direct contacts with Ran. In any case, it appears that
the RNA mimics of the NES reproduce faithfully at least
some of the structural and functional features of an NES.
We feel that these results represent a nontrivial outcome
for an anti-idiotype approach, considering that the
aptamers characterised here were isolated from combina-
torial libraries simply by selecting ligands with a poly-
clonal anti-peptide antibody.
The work described in this manuscript complements and
enhances the conclusions drawn from previously per-
formed selection experiments using antibodies against
proteins and peptides [30–34]. The selected RNA was in
all cases able to compete with the protein antigen for
binding to the antibody. Furthermore, the RNA mimics
interacted, in some cases, with heterogeneous antibodies
directed against the same protein epitope as the antibody
used for the selection of the RNA. These results
strengthen significantly the proposed models of structural
mimicry [30,34]. As pointed out previously [23,30,31,34],
in the absence of structural data that would allow the
direct comparison of antibody–RNA complexes with the
equivalent antibody–protein complexes, it is not possible
to exclude the possibility that the RNA–protein pairs,
including the Rev–XAP pair, would have only overlapping
binding sites rather than being true structural mimics. 
Strong support for models proposing the ability of RNA to
mimic protein domains comes from the work of Nyborg
and co-workers [35]. They have compared the crystal
structure of the elongation factor EF-G with the structure
of the trimeric tRNA–GDP–EF-Tu complex. The struc-
tures appear to be extremely similar and it was suggested
that the ability of EF-G to induce translocation of the
tRNA–GDP–EF-Tu complex on the ribosome might be
due to structural mimicry [35,36].
The NES-recognition domain
CRM1 is able to interact with RanGTP, LMB and the
NES. The Ran-binding domain could be localised to the
amino-terminal region of the protein due to its homology
with the Ran-binding domain of importin β [4,5]. The
LMB-binding site is expected to be located in the central
part of the protein based on the results of genetic screens
in S. pombe that identified point mutations in CRM1 (cor-
responding to Gly502 and Met545 in human CRM1)
leading to a reduced sensitivity to LMB [27]. Further-
more, it has been demonstrated that a single amino acid
difference between the S. cerevisiae and S. pombe/human
CRM1 (corresponding to position 528 of hCRM1, threo-
nine in S. cerevisiae and cysteine in human and S. pombe) is
the reason why the S. cerevisiae CRM1 does not bind to
LMB [28,29]. It therefore appears likely that at least part
of the LMB-binding site is located in the region between
amino acids 502 and 545, although formally the possibility
that the mutations affect the folding of CRM1 and that
the LMB-binding site is in a different part of the protein
cannot be excluded.
Very little is known about the NES-recognition domain of
CRM1. Protein footprinting experiments indicated that
residues 716 and 810 of CRM1 are protected in the pres-
ence of Rev protein against proteinase cleavage [16]. The
resolution of the protection assay, however, is relatively
low and the protected regions do not necessarily corre-
spond to the interaction surface between CRM1 and Rev.
The ability of the export aptamers to bind tightly to
CRM1 in the absence of Ran allowed us to separate the
requirements for their binding from the CRM1 domains
necessary for Ran binding or for the cooperative binding
of Ran and NES peptides or NES proteins. For the
reasons discussed above, it seems very probable that
export aptamer and NES–peptide binding to CRM1 will
involve overlapping regions of the protein. We have iden-
tified a region of 108 amino acids corresponding to
CRM1[493–600] that interacts specifically with the export
aptamer. This region is evolutionarily the most highly con-
served CRM1 domain across species, as might be
expected of the NES-recognition domain. As the amino
acids known to affect LMB-binding in yeast co-localise
with this putative NES-recognition domain and because
binding of export aptamers to CRM1 is LMB sensitive, it
is tempting to speculate that LMB inhibits CRM1-depen-
dent export by interfering with substrate binding.
Significance
The export of protein and RNA from the nucleus to the
cytoplasm is an active process that is dependent on
352 Chemistry & Biology  2000, Vol 7 No 5
cm7502.qxd  05/03/2000  09:07  Page 352
nuclear export signals (NESs). A functional NES is
required for the formation of productive export com-
plexes, which contain substrate, the NES receptor
CRM1/exportin1 and RanGTP [1–3,7–10]. CRM1 was
expected to contain three separate binding domains: one
for interaction with RanGTP, one for interaction with
the fungicide leptomycin B (LMB), which inhibits
CRM1 function by binding directly to the protein [7,15],
and the NES. The Ran-binding domain had been identi-
fied due to its homology with the known Ran-binding
domain of importin β [4,5]. The LMB domain was
expected to be located in the central domain of CRM1,
which contained the amino acids that resulted in altered
LMB sensitivity in genetic screens in Schizosaccha-
romyces pombe [25]. The substrate recognition domain
had not yet been identified.
We have used a novel approach to identify ligand-
binding domains of receptors. Anti-idiotype RNAs
(export aptamers) that were isolated with an anti-NES
antibody from combinatorial RNA libraries [17–22] and
were designed to mimic the Rev NES have been shown
to inhibit specifically Rev-mediated export in Xenopus
oocytes [23]. In this study we describe the characterisa-
tion of the interaction of CRM1 and export aptamer
RNA in vitro and demonstrate that the RNA is binding
tightly and specifically to CRM1. Furthermore, we have
used the export aptamer to map the putative NES-
recognition domain of CRM1 to a region of 108 amino
acids. This domain appears to co-localise with the previ-
ously identified LMB-binding domain of CRM1, which
suggests that LMB might inhibit CRM1 function by
blocking NES–CRM1 interactions.
In general, anti-idiotype RNA aptamers isolated with an
anti-ligand antibody can apparently mimic faithfully
some of the structural and functional properties of a
protein domain in vivo and in vitro [23,30,34]. This indi-
cates that anti-idiotype RNAs might be a valuable tool
to identify or to characterise protein–protein interac-
tions, and to disrupt them specifically.
Materials and methods
Native gels
Radioactively labelled RNA was prepared as described previously [21].
About 100 cps of [α-32P]-GTP-labelled, gel-purified RNA was incu-
bated with purified, recombinant protein (concentration 200 nM) in a
volume of 20 µl in reaction buffer (20 mM HEPES (pH 7.5), 110 mM
KOAc, 6 mM MgOAc, 2 mM DTT) for 10 min at room temperature.
87% glycerol (2 µl) were added and complexes analysed on nondena-
turing 6% acrylamide gels (6% acrylamide, 0.1% Triton X-100, 1×
TBE) as described [23]. For the competition experiments, proteins
were incubated in the presence of competitor for 20 min on ice.
Labelled RNA was added, the incubation was continued for 10 min at
room temperature and samples analysed as described. For the stem
mutants, deletions were introduced starting from position +4 (this
leaves G1–G3 which are required for efficient transcription by T7 RNA
polymerase) by deleting bases on both sides of the predicted stem
structure (stem12: ∆ U4–C9 + bases on the opposite stem side;
stem10: ∆ U4–C11 + opposite bases; stem8: ∆ U4–G13 + opposite
bases; stem6: ∆ U4–C15 + opposite bases).
Protein production
Recombinant proteins contained His6 tags and were prepared as
described [37]. CRM1 deletion mutants for translation in vitro were gen-
erated by attaching a T7 RNA polymerase promoter sequence and a
translational initiation sequence at the 5′-end (TAA TAC GAC TCA CTA
TAG GGA GAC CAC CAT G), and translational stop codons to the
3′-end of the CRM1 region to be transcribed and translated by PCR
using a CRM1 expression plasmid as a template. PCR fragments were
purified on 2% agarose gels and RNA transcribed with Promega Ribomax
kits. RNA was purified by phenol extraction, Sephadex G25 columns and
finally ethanol precipitation and was then resuspended in H2O at a con-
centration of 1 µg/µl. Proteins were translated in rabbit reticulocyte lysate
systems (Amersham) in the presence of 35S-methionine.
Precipitation of labelled CRM1 proteins
Templates for the transcription of XAP1, VGG, VTL, tRNA and 5S RNA
were prepared by PCR as described [21]. Purified fragments were
transcribed for 90 min in a volume of 100 µl with standard transcription
buffer (Stratagene) in the presence of 1.2 mM rNTPs, 0.12 mM bio-11
UTP, 50 u of T7RNA polymerase and 1 µl of RNase inhibitor. RNA was
purified by phenol extraction, sephadex G25 columns and finally
ethanol precipitation and resuspended in 30 µl H2O. Biotinylated RNA
(6 µl) was renatured for 10 min at 50°C in a volume of 25 µl (10 mM
Tris (pH 7.5), 100 mM KCl; 1 mM MgCl2). Dynal M280 streptavidin
beads (50 µl) were washed with 3 × 250 µl NaK150 (50 mM Tris-HCl
(pH 7.5), 100 mM KCl, 50 mM NaCl, 5 mM MgCl2), 0.1%NP-40 and
RNA was coupled to the beads by incubating washed beads in 25 µl of
renatured, biotinylated RNA and 200 µl NaK150/NP-40 for 20 min in a
rotating wheel (Dynal) at room temperature (RT). Beads were washed
3 × 3 min with 250 µl NaK150/NP-40 in the wheel. Translation lysate
(4 µl) containing the labelled proteins, 1.5 µl 1 mM yeast tRNA and
50 µl NaK150/NP-40 were incubated with the beads bound RNA for
15 min at RT in the rotating wheel and were washed 3 × 3 min with
250 µl NaK150/NP-40. Beads were suspended in 100 µl NaK150/NP-
40 and transferred to a fresh tube, the supernatant was removed and
beads boiled in 30 µl SDS-loading buffer. The supernatant (20 µl) was
analysed on 15% SDS-acrylamide gels (10 × 7.5 cm) that were run at
200 V for 60 min. Gels were treated with amplify (Amersham), dried
and exposed at –80°C for 6–12 h.
Precipitation of proteins from nuclear extracts
Biotinylated RNA was coupled to M280 beads and beads were
washed as described above. HeLa nuclear extract (16 µl; CCCC,
Belgium, 20 µg/µl), 32 µl 1 mM ytRNA and 52 µl H2O were incubated
for 30 min at room temperature in a rotating wheel and beads were
washed with NaK150 and analysed as described for the precipitation of
labelled proteins. Proteins were transferred to nitro-cellulose mem-
branes by semi-dry blotting and proteins detected with ECL-kits (Amer-
sham). Antibodies anti-CRM1 [4] anti-importin-β (kind gift of O. Gruss)
and anti-exportin (tRNA) [38] were diluted 1:1000.
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